ATE323693T1 - Calciumkanalantagonisten vom n-typ zur behandlung von schmerzen - Google Patents

Calciumkanalantagonisten vom n-typ zur behandlung von schmerzen

Info

Publication number
ATE323693T1
ATE323693T1 AT01981239T AT01981239T ATE323693T1 AT E323693 T1 ATE323693 T1 AT E323693T1 AT 01981239 T AT01981239 T AT 01981239T AT 01981239 T AT01981239 T AT 01981239T AT E323693 T1 ATE323693 T1 AT E323693T1
Authority
AT
Austria
Prior art keywords
treatment
pain
calcium channel
type calcium
channel antagonists
Prior art date
Application number
AT01981239T
Other languages
English (en)
Inventor
Bipinchandra Chaudhari
Marc Chapdelaine
Greg Hostetler
Lucius Kemp
John Mccauley
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Application granted granted Critical
Publication of ATE323693T1 publication Critical patent/ATE323693T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT01981239T 2000-11-06 2001-10-31 Calciumkanalantagonisten vom n-typ zur behandlung von schmerzen ATE323693T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0004053A SE0004053D0 (sv) 2000-11-06 2000-11-06 N-type calcium channel antagonists for the treatment of pain

Publications (1)

Publication Number Publication Date
ATE323693T1 true ATE323693T1 (de) 2006-05-15

Family

ID=20281713

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01981239T ATE323693T1 (de) 2000-11-06 2001-10-31 Calciumkanalantagonisten vom n-typ zur behandlung von schmerzen

Country Status (9)

Country Link
US (1) US6815447B2 (de)
EP (1) EP1339706B1 (de)
JP (1) JP2004513125A (de)
AT (1) ATE323693T1 (de)
AU (1) AU2002212894A1 (de)
DE (1) DE60118956T2 (de)
ES (1) ES2261496T3 (de)
SE (1) SE0004053D0 (de)
WO (1) WO2002036586A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040259866A1 (en) * 1998-06-30 2004-12-23 Snutch Terrance P. Calcium channel blockers comprising two benzhydril moieties
PL375552A1 (en) 2002-05-22 2005-11-28 Amgen Inc. Vanilloid receptor ligands and their medical applications
CA2493667C (en) * 2002-08-08 2010-04-27 Amgen Inc. Vanilloid receptor ligands and their use in treatments
US7419984B2 (en) * 2002-10-17 2008-09-02 Cell Therapeutics, Inc. Pyrimidines and uses thereof
AU2003295776B2 (en) 2002-11-21 2011-05-12 Novartis Vaccines And Diagnostics, Inc. 2,4,6-trisubstituted pyrimidines as phosphotidylinositol (PI) 3-kinase inhibitors and their use in the treatment of cancer
EP1691812A4 (de) * 2003-11-20 2010-01-13 Childrens Hosp Medical Center Gtpase-hemmer und anwendungsverfahren
US7301022B2 (en) 2005-02-15 2007-11-27 Amgen Inc. Vanilloid receptor ligands and their use in treatments
US20080300262A1 (en) * 2005-04-08 2008-12-04 Snutch Terrance P Combination Therapy for Relief of Pain
JO2660B1 (en) 2006-01-20 2012-06-17 نوفارتيس ايه جي Pi-3 inhibitors and methods of use
WO2007133481A2 (en) * 2006-05-11 2007-11-22 Neuromed Pharmaceuticals Ltd. Method for increasing the bioavailability of benzhydryl piperazine containing compounds
ATE551334T1 (de) 2007-02-06 2012-04-15 Novartis Ag Pi3-kinase-hemmer und verfahren zu ihrer verwendung
KR101761963B1 (ko) * 2010-03-04 2017-07-26 머크 샤프 앤드 돔 코포레이션 카테콜 ｏ－메틸 트랜스퍼라제의 억제제 및 정신병적 장애의 치료에서의 그의 용도
AU2011223969B2 (en) * 2010-03-04 2015-06-11 Merck Sharp & Dohme Llc Inhibitors of catechol O-methyl transferase and their use in the treatment of psychotic disorders
EP2542077A4 (de) * 2010-03-04 2013-08-21 Merck Sharp & Dohme Hemmer der catechol-o-methyl-transferase und ihre verwendung bei der behandlung psychotischer störungen
KR20140011366A (ko) 2011-03-08 2014-01-28 잘리커스 파마슈티컬즈 리미티드 고체 분산체 제형 및 그의 이용방법
US8409560B2 (en) 2011-03-08 2013-04-02 Zalicus Pharmaceuticals Ltd. Solid dispersion formulations and methods of use thereof
PH12014500682A1 (en) 2011-09-27 2014-05-12 Novartis Ag 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant idh
UY34632A (es) 2012-02-24 2013-05-31 Novartis Ag Compuestos de oxazolidin- 2- ona y usos de los mismos
US9296733B2 (en) 2012-11-12 2016-03-29 Novartis Ag Oxazolidin-2-one-pyrimidine derivative and use thereof for the treatment of conditions, diseases and disorders dependent upon PI3 kinases
GEP201706699B (en) 2013-03-14 2017-07-10 Novartis Ag 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant idh

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB794043A (en) * 1955-06-03 1958-04-30 Ici Ltd New quinoline derivatives
RU2202344C2 (ru) * 1998-03-26 2003-04-20 Джапан Тобакко Инк. Антагонисты ноцицептина, производные амида, аналгетик, способ инициирования антагонистического действия к ноцицептину, способ лечения боли, фармацевтические композиции

Also Published As

Publication number Publication date
SE0004053D0 (sv) 2000-11-06
DE60118956D1 (de) 2006-05-24
US6815447B2 (en) 2004-11-09
EP1339706B1 (de) 2006-04-19
ES2261496T3 (es) 2006-11-16
EP1339706A1 (de) 2003-09-03
JP2004513125A (ja) 2004-04-30
WO2002036586A1 (en) 2002-05-10
US20040058945A1 (en) 2004-03-25
DE60118956T2 (de) 2007-03-15
AU2002212894A1 (en) 2002-05-15

Similar Documents

Publication Publication Date Title
ATE323693T1 (de) Calciumkanalantagonisten vom n-typ zur behandlung von schmerzen
ATE296094T1 (de) Stickstoffmonoxid bildende zusammensetzungen zur behandlung von nagelbettinfektionen
ATE455092T1 (de) Substituierte tetracyclin-verbindungen zur behandlung von malaria
ATE295837T1 (de) Antagonisten für calciumkanäle vom n-typ zur behandlung von schmerzen
CA2366932A1 (en) Cyclic protein tyrosine kinase inhibitors
IS6658A (is) Ný efnasambönd
DE50206657D1 (de) Pharmazeutische zusammensetzung zur behandlung von multiple sklerose
ATE284690T1 (de) Antithrombotische diamine
ATE407676T1 (de) Topoisomerasehemmern zur behandlung von chirurgischen verklebungen
ATE363290T1 (de) Cd40 antagonist zur behandlung von psoriasis
PL1654253T3 (pl) Podstawione pochodne 3-pirolidynoindolu
DE10082139T1 (de) Zusammensetzung zur Behandlung von Reibungspaaren
SE0302139D0 (sv) Novel compounds
CY1113116T1 (el) Υποκατεστημενες 4-αμινοκυκλοεξανολες
SE0004054D0 (sv) N-type calcium channel antagonists for the treatment of pain
SE9802208D0 (sv) Novel compounds
YU13301A (sh) Muskarinski agonisti i antagonisti
DE502005008058D1 (de) Gesättigte und ungesättigte 3-pyridyl-benzocycloalkylmethyl-amine zur behandlung von schmerzen, depressionen und angstzuständen
EA199700032A1 (ru) Дезинфицирующий состав "велтолен"
SE0003476D0 (sv) Compounds
ATE457027T1 (de) Substituierte 1,4,8-triazaspiroä4.5 decan-2-on- verbindungen zur behandlung von fettsucht
SE0303280D0 (sv) Novel compounds
ATE421502T1 (de) Calciumkanalantagonisten vom n-typ zur behandlung von schmerzen
SE9802209D0 (sv) Novel compounds
SE0302755D0 (sv) Novel compounds

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties